AAAAAA

   
Results: 1-9 |
Results: 9
Concomitant twice-a-day radiotherapy and chemotherapy in unresectable headand neck cancer patients: A long-term quality of life analysis
Authors: Magne, N Marcy, PY Chamorey, E Guardiola, E Pivot, X Schneider, M Demard, F Bensadoun, RJ
Citation: N. Magne et al., Concomitant twice-a-day radiotherapy and chemotherapy in unresectable headand neck cancer patients: A long-term quality of life analysis, HEAD NECK, 23(8), 2001, pp. 678-682
The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy
Authors: Magne, N Pivot, X Bensadoun, RJ Guardiola, E Poissonnet, G Dassonville, O Francoual, M Formento, JL Demard, F Schneider, M Milano, G
Citation: N. Magne et al., The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy, EUR J CANC, 37(17), 2001, pp. 2169-2177
Combination of cisplatin-doxorubicin-cyclophosphamide in adenocarcinoma ofunknown primary site - A phase II trial
Authors: Guardiola, E Pivot, X Tchicknavorian, X Magne, N Otto, J Thyss, A Schneider, M
Citation: E. Guardiola et al., Combination of cisplatin-doxorubicin-cyclophosphamide in adenocarcinoma ofunknown primary site - A phase II trial, AM J CL ONC, 24(4), 2001, pp. 372-375
Clinical prognostic factors for patients with recurrent head and neck cancer: Implications for randomized trials
Authors: Pivot, X Niyikiza, C Poissonnet, G Dassonville, O Bensadoun, RJ Guardiola, E Benezery, CF Demard, F Schneider, A Schneider, M
Citation: X. Pivot et al., Clinical prognostic factors for patients with recurrent head and neck cancer: Implications for randomized trials, ONCOL-BASEL, 61(3), 2001, pp. 197-204
Phase II trial of a paclitaxel-carboplatin combination in recurrent squamous cell carcinoma of the head and neck
Authors: Pivot, X Cals, L Cupissol, D Guardiola, E Tchiknavorian, X Guerrier, P Merad, L Wendling, JL Barnouin, L Savary, J Thyss, A Schneider, M
Citation: X. Pivot et al., Phase II trial of a paclitaxel-carboplatin combination in recurrent squamous cell carcinoma of the head and neck, ONCOL-BASEL, 60(1), 2001, pp. 66-71
Incorrect citation of autors: only an unpolite issue?
Authors: Guardiola, E Banos, JE
Citation: E. Guardiola et Je. Banos, Incorrect citation of autors: only an unpolite issue?, MED CLIN, 116(3), 2001, pp. 118-118
An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia
Authors: Pivot, X Guardiola, E Etienne, MC Thyss, A Foa, C Otto, J Schneider, M Magne, N Bensadoun, RJ Renee, N Milano, G
Citation: X. Pivot et al., An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia, EUR J CANC, 36(7), 2000, pp. 852-857
Kinetic model for anaerobic digestion of livestock manure
Authors: Garcia-Ochoa, F Santos, VE Naval, L Guardiola, E Lopez, B
Citation: F. Garcia-ochoa et al., Kinetic model for anaerobic digestion of livestock manure, ENZYME MICR, 25(1-2), 1999, pp. 55-60
A double blind, randomised, placebo controlled study to assess the maximuminsulin dose reduction achieved with acarbose in the treatment of insulin-requiring Type 2 diabetic patients
Authors: Pinol, C Guardiola, E Soler, J Cano, F Mijares, AH Jimenez, A de Leiva, A Arroyo, JA
Citation: C. Pinol et al., A double blind, randomised, placebo controlled study to assess the maximuminsulin dose reduction achieved with acarbose in the treatment of insulin-requiring Type 2 diabetic patients, DIABET NUTR, 11(4), 1998, pp. 242-248
Risultati: 1-9 |